Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study. Read more about Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study.
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Read more about Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.
Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10). Read more about Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10).
Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment. Read more about Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment.
Evaluation of URO17® to improve non-invasive detection of bladder cancer. Read more about Evaluation of URO17® to improve non-invasive detection of bladder cancer.
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era. Read more about Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era.
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials. Read more about Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Read more about Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life.
Interruptions in bladder cancer care during the COVID-19 public health emergency. Read more about Interruptions in bladder cancer care during the COVID-19 public health emergency.
Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Read more about Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer.
